CYPHERPUNK TECHNOLOGIES INC.
CYPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509745
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 20266:14 PM ET | Sep 25, 2026 | Oei Khing DjienDirector | SSaleCommon Stock | −168.75K | $3.92 | −$661.5K | 0 | −100.0% | SEC |
| Sep 25, 20266:13 PM ET | Sep 23, 2026 | Martin Patricia A.Director | SSaleCommon Stock | −50K | $3.86 | −$193K | 118.75K | −29.6% | SEC |
| Aug 27, 20264:30 PM ET | Aug 26, 2026 | Dietz Thomas JohnDirector | SSaleCommon Stock | −20K | $1.72 | −$34.4K | 132.5K | −13.1% | SEC |
| Mar 30, 2026 | Mar 26, 2026 | Mirabelli ChristopherDirector | SSaleCommon Stock | −60K | $0.71 | −$42.6K | 130.38K | −31.5% | SEC |
| Nov 19, 2025 | Nov 17, 2025 | Mirabelli ChristopherDirector | SSaleCommon Stock | −676.32K | $3.14 | −$2.12M | 2.14K | −99.7% | SEC |
| Nov 19, 2025 | Nov 17, 2025 | CAVANAUGH JAMES HDirector | SSaleCommon Stock | −261.84K | $3.14 | −$822.18K | 0 | −100.0% | SEC |
| Nov 19, 2025 | Nov 17, 2025 | ONSI DOUGLAS ECEO,CFO,Pres.,GC,Treas.&Sec. | SSaleCommon Stock | −676.32K | $3.14 | −$2.12M | 2.14K | −99.7% | SEC |
| Sep 28, 20214:21 PM ET | Sep 24, 2021 | EDELMAN JOSEPH and 2 others10% Owner | PPurchaseCommon Stock · Derivative | +3.51M | $2.849 | +$10M | 3.51M | – | SEC |
| Sep 28, 2021 | Sep 24, 2021 | BeiGene, Ltd.10% Owner | PPurchaseCommon Stock | +2.54M | $2.85 | +$7.25M | 7.35M | +52.9% | SEC |